These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2596811)

  • 21. [Clinical studies of a new non-ionic contrast medium--iohexol (Omnipaque)--in patients sensitive to ionic contrast medium].
    Fuse H; Miyazaki K; Nakasima T; Fujita Y
    Hinyokika Kiyo; 1989 Feb; 35(2):371-5. PubMed ID: 2735246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Indications and contraindications of cerebral arteriography in gravely ill patients suffering from diseases of the nervous system].
    Arseni C; Maretsis M
    Neurol Psihiatr Neurochir; 1971; 16(2):133-40. PubMed ID: 5578352
    [No Abstract]   [Full Text] [Related]  

  • 23. Intracerebral leakage of contrast medium in apoplexy.
    Yamaguchi K; Uemura K; Takahashi H; Kowada M; Kutsuzawa T
    Br J Radiol; 1971 Sep; 44(525):689-91. PubMed ID: 5569964
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of iohexol, iopamidol, iopromide, and iosimide compared with meglumine diatrizoate.
    Hartwig P; Mützel W; Taenzer V
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():220-3. PubMed ID: 2568800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iopromide-induced encephalopathy following coronary angioplasty.
    Kocabay G; Karabay CY
    Perfusion; 2011 Jan; 26(1):67-70. PubMed ID: 20921088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of an ionic and a nonionic (sodium meglumine diatrizoate and iopromide) x-ray contrast medium of hemorrheology.
    Strecker EP; Stengel M; Witte S
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():24-7. PubMed ID: 2568803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerance of iopromide in angiography: a multicenter study.
    Langer M; Behrends B; Langer R; Eichstädt H; Jänicke UA
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():61-6. PubMed ID: 2568810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of a new contrast medium (Angiografin) in cerebral angiography].
    Smaltino F; Bernini FP; Elefante R
    Nunt Radiol; 1969 Mar; 35(3):263-70. PubMed ID: 5405699
    [No Abstract]   [Full Text] [Related]  

  • 29. Are iodinated contrast agents detrimental in acute cerebral ischemia? An experimental study in rats.
    Doerfler A; Engelhorn T; von Kummer R; Weber J; Knauth M; Heiland S; Sartor K; Forsting M
    Radiology; 1998 Jan; 206(1):211-7. PubMed ID: 9423675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of the nonionic contrast medium iopromide in end-stage renal failure by hemodialysis.
    Kierdorf H; Kindler J; Winterscheid R; Hollmann HJ; Vorwerk D; Speck U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():119-23. PubMed ID: 2568779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pediatric angiocardiography. Randomized, controlled study of 2 iodinated contrast media: iopromide 300 and ioxaglate 320 mgI/ml].
    Amiel M; Revel D
    Ann Radiol (Paris); 1989; 32(4 Pt 2):336-8. PubMed ID: 2688530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial experience with a nonionic, dimeric contrast medium (iotrolan) in direct and indirect arteriography: a randomized, intraindividual double-blind study in 60 patients.
    Hagen B; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():54-60. PubMed ID: 2568808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Iopromide 300 and 370. Meta-analysis of a randomized prospective clinical trial conducted in France in 1987. Overall results of tolerability and efficacy].
    Broussel R
    Ann Radiol (Paris); 1989; 32(4 Pt 2):329-32. PubMed ID: 2688528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience with iobitridol 250-300 in digital subtraction angiography. Double-blind randomized studies vs. iopromide and iohexol.
    Bouard JC; Lyonnet D; Illes JP; Bouard-Monnier C; Rouviere O; Pangaud C
    Acta Radiol Suppl; 1996; 400():85-8. PubMed ID: 8619361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with iohexol versus iopromide in excretory urography.
    Bischoff W
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():108-10. PubMed ID: 2568776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experiences with the nonionic contrast medium iopamidol in cerebral angiography].
    Purmann H; Bradac GB
    Rontgenblatter; 1985 Feb; 38(2):51-3. PubMed ID: 3983536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of iohexol with meglumine-Na diatrizoate for intravenous digital subtraction angiography.
    Seeger JF; Carmody RF; Smith JR; Horsley WW; Criss E
    Acta Radiol Suppl; 1983; 366():85-8. PubMed ID: 6382940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients.
    Palkowitsch PK; Bostelmann S; Lengsfeld P
    Acta Radiol; 2014 Jul; 55(6):707-14. PubMed ID: 24043880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of retrograde brachial arteriography for visualization of the carotid and vertebral arteries].
    Buffard P; Thierry A; Eyssette M; Bigay JL; Dechaume JP; Fischer G
    Neurochirurgie; 1966; 12(5):570-80. PubMed ID: 5971254
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of intravenous angiography and conventional arteriography in the diagnosis of atheromatous lesions of supra-aortic trunks].
    Bonafe A; Ducos de Lahitte M; Marc-Vergnes JP; Barret A; Manelfe C
    Ann Radiol (Paris); 1983 Nov; 26(7):602-5. PubMed ID: 6364943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.